Related references
Note: Only part of the references are listed.Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
Colin Bergstrom et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients
Tea Nizic-Kos et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Characterization of New ATM Deletion Associated with Hereditary Breast Cancer
Sandra Parenti et al.
GENES (2021)
Structural basis of homologous recombination
Yueru Sun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation
Victoria Teoh et al.
CANCERS (2020)
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
Claudia Piombino et al.
JOURNAL OF ONCOLOGY (2020)
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Lenka Stolarova et al.
CELLS (2020)
Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?
Laura Cortesi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer
Petra Kleiblova et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
Hsiao-Mei Lu et al.
JAMA ONCOLOGY (2019)
Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis
Delal Akdeniz et al.
BREAST (2019)
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations
Jaya Singh et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications
Angela Toss et al.
Oncotarget (2018)
Morphology and genomic hallmarks o breast tumours developed by &ITATM&IT deleterious variant carriers
Anne-Laure Renault et al.
BREAST CANCER RESEARCH (2018)
Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2
Cornelia Kraus et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Marie Eliade et al.
ONCOTARGET (2017)
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
Angela Toss et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Koji Shindo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Matthew B. Yurgelun et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study
Laura Cortesi et al.
ONCOLOGY (2017)
Non-BRCA familial breast cancer: review of reported pathology and molecular findings
Michael G. Keeney et al.
PATHOLOGY (2017)
Germline Genetic Variants in Men with Prostate Cancer and One or More Additional Cancers
Patrick G. Pilie et al.
CANCER (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
S. Paluch-Shimon et al.
ANNALS OF ONCOLOGY (2016)
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk
Monica Marabelli et al.
GENETIC EPIDEMIOLOGY (2016)
Improving performance of multigene panels for genomic analysis of cancer predisposition
Brian H. Shirts et al.
GENETICS IN MEDICINE (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer
Nimmi S. Kapoor et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
Maarten P. G. Massink et al.
BMC CANCER (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
Fergus J. Couch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis
Cezary Cybulski et al.
LANCET ONCOLOGY (2015)
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond et al.
JAMA ONCOLOGY (2015)
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women
L. Cortesi et al.
ANNALS OF ONCOLOGY (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Acceptability and Adherence in a Chemoprevention Trial among Women at Increased Risk for Breast Cancer Attending the Modena Familial Breast and Ovarian Cancer Center (Italy)
Elisabetta Razzaboni et al.
BREAST JOURNAL (2013)
Relative and disease-free survival for breast cancer in relation to subtype: a population-based study
Pamela Minicozzi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Personalized genomic disease risk of volunteers
Manuel L. Gonzalez-Garay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The CHEK2 I157T Variant and Breast Cancer Susceptibility: A Systematic Review and Meta-analysis
Chuan Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer
Pawel Domagala et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Kirsi M. Kuusisto et al.
BREAST CANCER RESEARCH (2011)
CHEK2 contribution to hereditary breast cancer in non-BRCA families
Alexis Desrichard et al.
BREAST CANCER RESEARCH (2011)
Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study
Jonine L. Bernstein et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention
C. Cybulski et al.
CLINICAL GENETICS (2009)
Age at Onset of Bilateral Breast Cancer, the Presence of Hereditary BRCA1, BRCA2, CHEK2 Gene Mutations and Positive Family History of Cancer
Elzbieta Skasko et al.
ONKOLOGIE (2009)
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study
Antonino Musolino et al.
BREAST (2007)
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience
Laura Cortesi et al.
BMC CANCER (2006)
ATM variants and cancer risk in breast cancer patients from Southern Finland
Johanna Tommiska et al.
BMC CANCER (2006)
Chk2 molecular interaction map and rationale for Chk2 inhibitors
Y Pommier et al.
CLINICAL CANCER RESEARCH (2006)
Pathology of breast cancer in women with constitutional CHEK2 mutations
T Huzarski et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients
O Kilpivaara et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy
MA Caligo et al.
HUMAN MUTATION (2004)
Mutations in CHEK2 associated with prostate cancer risk
XY Dong et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer
P Vahteristo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Ionizing radiation activates the ATM kinase throughout the cell cycle
TK Pandita et al.
ONCOGENE (2000)
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility
A Broeks et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
